Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HTLV-I-associated leukemia/lymphoma in south Florida.

W J Harrington1, G A Miller, R R Kemper

  • 1Division of Genetics, William J. Harrington Center for Blood Diseases, School of Medicine, Florida.

Journal of Acquired Immune Deficiency Syndromes
|January 11, 1991
PubMed
Summary

This study identified 10 cases of aggressive adult T-cell leukemia/lymphoma (ATL) in South Florida, all linked to human T-lymphotropic virus type I (HTLV-I) infection. The findings highlight the importance of considering HTLV-I in non-Hodgkin's lymphoma diagnoses within at-risk populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging functional brain connectivity patterns from high-resolution EEG and fMRI via graph theory.

Psychophysiology·2007
Same author

Improved estimation of human cortical activity and connectivity with the multimodal integration of neuroelectric and hemodynamic data.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference·2007
Same author

Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) for treatment of dialysis access-associated steal syndrome.

Kidney international·2006
Same author

Evaluation of an upper hive entrance for control of Aethina tumida (Coleoptera: Nitidulidae) in colonies of honey bees (Hymenoptera: Apidae).

Journal of economic entomology·2006
Same author

Auditory sensory gating deficit and cortical thickness in schizophrenia.

Neurology & clinical neurophysiology : NCN·2005
Same author

HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up.

European journal of gynaecological oncology·2004

Area of Science:

  • Oncology
  • Virology
  • Hematology

Background:

  • Adult T-cell leukemia/lymphoma (ATL) is an aggressive malignancy.
  • Human T-lymphotropic virus type I (HTLV-I) is a known cause of ATL.
  • ATL prevalence varies geographically, particularly in endemic regions.

Purpose of the Study:

  • To report on cases of ATL diagnosed in South Florida.
  • To investigate the association between HTLV-I and non-Hodgkin's lymphoma in this patient cohort.
  • To determine the prevalence of HTLV-I-related lymphoma in the studied population.

Main Methods:

  • Retrospective case series of 10 ATL patients diagnosed between February 1988 and July 1989.
  • Serological testing for HTLV-I and HIV-1.
  • Polymerase chain reaction (PCR) and blot hybridization for HTLV-I proviral DNA detection.

Related Experiment Videos

  • Analysis of patient demographics, clinical presentation, and outcomes.

    • Main Results:

    • All 10 patients were HTLV-I seropositive and HIV-1 seronegative.
    • HTLV-I proviral DNA was detected in tumor biopsies/lymphocytes of nine patients.
    • Monoclonal integration of HTLV-I proviral DNA confirmed ATL diagnosis in seven patients.
    • The majority of patients were women, with origins from the Caribbean.
    • All patients presented with aggressive non-Hodgkin's lymphoma, often with hypercalcemia and poor prognosis (8/10 died within 1 year).
    • ATL represented 15% of non-Hodgkin's lymphoma cases in this sample.

    Conclusions:

    • HTLV-I infection is strongly associated with ATL in this South Florida cohort.
    • A significant proportion of non-Hodgkin's lymphoma cases in this population may be attributable to HTLV-I.
    • Clinicians should consider HTLV-I as a potential etiology for non-Hodgkin's lymphoma, especially in patients from HTLV-I endemic regions.